US analytics specialist Phesi has called for a major rethink in how oncology trials are planned and run, saying clinical ...

US pharma giant Pfizer will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 ...

US President Donald Trump released an executive order on May 12 calling for a 30-day negotiation period between the ...

Chicago-based pharma major AbbVie and privately-held San Diego biotech ADARx Pharmaceuticals have announced a collaboration ...

In a further bid to expand its already lucrative portfolio of metabolic and obesity medicines, Denmark’s Novo Nordisk (NOV: N ...

UK-based Kaerus Bioscience, a biopharma created by European investment firm Medicxi for the development of therapeutics for ...

Fibrosis drug developer Tvardi Therapeutics has hit the ground running after completing its merger with troubled US biotech ...

US biotech Cytokinetics has unveiled fresh Phase III data backing its heart drug aficamten, showing the treatment was more ...

San Diego, USA-based biotech Capricor Therapeutics (Nasdaq; CAPR) yesterday announced the appointment of Dr Michael Binks as ...

Cambridge, USA-based biotech Stylus Medicine, which says it is dedicated to developing transformative in vivo genetic ...

Danish CNS specialist Lundbeck (LUND: CO) today released first-quarter 2025 financials, along with a raised guidance for the ...

A clinical-stage, immunology-focused biopharmaceutical company developing skin-related treatments. Founded in 2010, the company is headquartered in Singapore and has offices in Taiwan and China. ASLAN ...